Plus Therapeutics (PSTV) Appoints Eric Daniels as Chief Development Officer

AI Summary

Plus Therapeutics (PSTV) announced the appointment of Eric Daniels as chief development officer. This leadership change is part of the company's strategy to advance its clinical and regulatory efforts. Eric brings extensive experience in medicine and drug development, which may improve PSTV's competitive position in the market. The appointment is expected to drive progress in Plus Therapeutics' pipeline and operational efficiency.